How does a treatment with anti-Rh antibodies (RhoGAM)prevent hemolytic disease of the newborn (HDN)?

Question

Quizplus · Accepted Answer

RhoGAM works by targeting and destroying any fetal Rh-positive red blood cells (RBCs) that enter the maternal circulation before the mother's immune system can detect them and produce antibodies against them. This prevents the mother from becoming sensitized to Rh-positive blood, thereby avoiding the production of antibodies that could cross the placenta and cause hemolytic disease of the newborn in future pregnancies.

How Does a Treatment with Anti-Rh Antibodies (RhoGAM)prevent Hemolytic Disease